100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
COMPLETE TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH FIFTH, NORTH AMERICAN EDITION BY VIRGINIA POOLE ARCANGELO | ANDREW M. PETERSON|LATEST 2024/2025|VERIFIED ANSWERS PRINTED PDF|ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VE $18.49   Add to cart

Exam (elaborations)

COMPLETE TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH FIFTH, NORTH AMERICAN EDITION BY VIRGINIA POOLE ARCANGELO | ANDREW M. PETERSON|LATEST 2024/2025|VERIFIED ANSWERS PRINTED PDF|ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VE

 4 views  0 purchase
  • Course
  • PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRAC
  • Institution
  • PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRAC

COMPLETE TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH FIFTH, NORTH AMERICAN EDITION BY VIRGINIA POOLE ARCANGELO | ANDREW M. PETERSON|LATEST 2024/2025|VERIFIED ANSWERS PRINTED PDF|ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VERIFIED ANSWERS| DOWNLOAD IMMEDIETLY AFTE...

[Show more]

Preview 4 out of 452  pages

  • October 2, 2024
  • 452
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:
  • PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRAC
  • PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRAC
avatar-seller
PROFFESSIONALTUTORJOANA
COMPLETE TEST BANK
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH
FIFTH, NORTH AMERICAN EDITION BY VIRGINIA POOLE ARCANGELO | ANDREW
M. PETERSON|LATEST 2024/2025|VERIFIED ANSWERS
PRINTED PDF|ORIGINAL DIRECTLY FROM THE PUBLISHER| 100% VERIFIED ANSWERS| DOWNLOAD

IMMEDIETLY AFTER THE ORDER

,TABLE OF CONTENTS
UNIT 1 PRINCIPLES OF THERAPEUTICS ......................................................................................................... 4
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY .............................................................. 4
CHAPTER 2.PHARMACOKINETIC BASIS OF THERAPEUTICS AND PHARMACODYNAMIC .......................... 5
CHAPTER 3. IMPACT OF DRUG INTERACTIONS AND ADVERSE EVENTS ON THERAPEUTICS .................. 13
CHAPTER 4: PRINCIPLES OF PHARMACOTHERAPY IN PEDIATRICS, PREGNANCY, AND LACTATION ...... 18
CHAPTER 5. PHARMACOTHERAPY PRINCIPLES IN OLDER ADULTS ......................................................... 23
CHAPTER 6. PRINCIPLES OF ANTIMICROBIAL THERAPY .......................................................................... 26
CHAPTER 7. PHARMACOGENOMICS ....................................................................................................... 31
CHAPTER 8. THE ECONOMICS OF PHARMACOTHERAPEUTICS ............................................................... 34
UNIT 2: PRINCIPLES OF PAIN MANAGEMENT ............................................................................................. 38
CHAPTER 9 PRINCIPLES OF PHARMACOTHERAPY IN PAIN MANAGEMENT ........................................... 38
CHAPTER 10: PAIN MANAGEMENT IN OPIOID USE DISORDER (OUD) PATIENTS ................................... 42
CHAPTER 11: CANNABIS AND PAIN MANAGEMENT ............................................................................... 64
UNIT 3: PHARMACOTHERAPY FOR SKIN DISORDERS .................................................................................. 76
CHAPTER 12. CONTACT DERMATITIS ...................................................................................................... 76
CHAPTER 13: BACTERIAL, FUNGAL, AND VIRAL INFECTIONS OF THE SKIN............................................. 80
CHAPTER 14. PSORIASIS .......................................................................................................................... 90
CHAPTER 15. ACNE VULGARIS AND ROSACEA ........................................................................................ 92
UNIT 4: PHARMACOTHERAPY FOR EYE AND EAR DISORDERS .................................................................... 94
CHAPTER 16 OPHTHALMIC DISORDERS .................................................................................................. 94
CHAPTER 17. OTITIS MEDIA AND OTITIS EXTERNA ................................................................................. 98
UNIT 5: PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS ......................................................... 102
CHAPTER 18. HYPERTENSION ............................................................................................................... 102
CHAPTER 19. HYPERLIPIDEMIA ............................................................................................................. 106
CHAPTER 20: CHRONIC STABLE ANGINA AND MYOCARDIAL INFARCTION .......................................... 110
CHAPTER 21. HEART FAILURE ............................................................................................................... 152
CHAPTER 22: ARRHYTHMIAS ................................................................................................................ 156
UNIT 6: PHARMACOTHERAPY FOR RESPIRATORY DISORDERS ................................................................. 164
CHAPTER 23: RESPIRATORY INFECTIONS .............................................................................................. 164
CHAPTER 24: ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE ...................................... 173
UNIT 7: PHARMACOTHERAPY FOR GASTROINTESTINAL DISORDERS ....................................................... 178
CHAPTER 25: GASTRIC, FUNCTIONAL AND INFLAMMATORY BOWEL DISORDERS .............................. 178

, CHAPTER 26. GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER DISEASE ............................ 197
CHAPTER 27: LIVER DISEASES ............................................................................................................... 200
UNIT 8: PHARMACOTHERAPY FOR GENITOURINARY TRACT DISORDERS................................................. 218
CHAPTER 28. URINARY TRACT INFECTIONS .......................................................................................... 218
CHAPTER 29. PROSTATIC DISORDERS AND ERECTILE DYSFUNCTION ................................................... 221
CHAPTER 30. OVERACTIVE BLADDER .................................................................................................... 245
CHAPTER 31. SEXUALLY TRANSMITTED INFECTIONS ............................................................................ 248
UNIT 9: PHARMACOLOGY FOR MUSCULOSKELETAL DISORDERS ............................................................. 250
CHAPTER 32. OSTEOARTHRITIS AND GOUT .......................................................................................... 250
CHAPTER 33. OSTEOPOROSIS ............................................................................................................... 256
CHAPTER 34. RHEUMATOID ARTHRITIS ................................................................................................ 259
UNIT 10: PHARMACOTHERAPY FOR NEUROLOGICAL DISORDERS ........................................................... 276
CHAPTER 35. HEADACHES ..................................................................................................................... 276
CHAPTER 36. SEIZURE DISORDERS ........................................................................................................ 280
CHAPTER 37. ALZHEIMER’S DISEASE ..................................................................................................... 283
CHAPTER 38. PARKINSON DISEASE ....................................................................................................... 285
UNIT 11: PHARMACOTHERAPY FOR MENTAL HEALTH DISORDERS .......................................................... 293
CHAPTER 39: MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDERS ............................................ 293
CHAPTER 40. ANXIETY DISORDERS ....................................................................................................... 322
CHAPTER 41. SLEEP DISORDERS ............................................................................................................ 360
CHAPTER 42. ATTENTION DEFICIT HYPERACTIVITY DISORDER ............................................................. 361
CHAPTER 43: SUBSTANCE USE DISORDERS........................................................................................... 363
UNIT 12: PHARMACOTHERAPY FOR ENDOCRINE DISORDERS .................................................................. 371
CHAPTER 44. DIABETES MELLITUS ........................................................................................................ 371
CHAPTER 45: THYROID AND PARATHYROID DISORDERS ...................................................................... 378
UNIT 13: PHARMACOTHERAPY FOR IMMUNOLOGY ................................................................................ 398
CHAPTER 46. ALLERGIES AND ALLERGIC REACTIONS............................................................................ 398
CHAPTER 47. HUMAN IMMUNODEFICIENCY VIRUS ............................................................................. 401
CHAPTER 48: ORGAN TRANSPLANTATION............................................................................................ 405
UNIT 14: PHARMACOTHERAPY FOR THROMBOEMBOLIC DISORDERS ..................................................... 414
CHAPTER 49: PHARMACOTHERAPY FOR SELECT THROMBOEMBOLIC DISORDERS.............................. 414
CHAPTER 50. ANEMIAS ......................................................................................................................... 421
UNIT 15: PHARMACOTHERAPY FOR HEALTH PROMOTION ...................................................................... 425

, CHAPTER 51. IMMUNIZATIONS ............................................................................................................ 425
CHAPTER 52. SMOKING CESSATION ..................................................................................................... 429
CHAPTER 53. WEIGHT LOSS .................................................................................................................. 432
UNIT 16: PHARMACOTHERAPY FOR WOMEN’S HEALTH .......................................................................... 435
CHAPTER 54. CONTRACEPTION............................................................................................................. 435
CHAPTER 55. MENOPAUSE ................................................................................................................... 438
CHAPTER 56. VAGINITIS ........................................................................................................................ 450



UNIT 1 PRINCIPLES OF THERAPEUTICS
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY



MULTIPLE CHOICE

1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:

A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING

B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION

C. THE STATE BOARD OF NURSING FOR EACH STATE

D. THE STATE BOARD OF PHARMACY

CORRECT ANS>C PTS: 1

2. PHYSICIAN ASSISTANT (PA) PRESCRIPTIVE AUTHORITY IS REGULATED BY:

A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING

B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION

C. THE STATE BOARD OF NURSING

D. THE STATE BOARD OF MEDICAL EXAMINERS

CORRECT ANS>D PTS: 1

3. CLINICAL JUDGMENT IN PRESCRIBING INCLUDES:

A. FACTORING IN THE COST TO THE PATIENT OF THE MEDICATION PRESCRIBED

B. ALWAYS PRESCRIBING THE NEWEST MEDICATION AVAILABLE FOR THE DISEASE PROCESS

C. HANDING OUT DRUG SAMPLES TO POOR PATIENTS

D. PRESCRIBING ALL GENERIC MEDICATIONS TO CUT COSTS

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller PROFFESSIONALTUTORJOANA. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $18.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

77333 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$18.49
  • (0)
  Add to cart